Intersect ENT, a global ear, nose and throat medical technology company, entered into a $60 million secured term loan agreement with a fund managed by Deerfield Management Company.
Deerfield Healthcare Technology Acquisitions closed its business combination with CareMax Medical Group and IMC Medical Group Holdings. The combination was partially funded by $125 million in financing from a $185 million credit facility from RBC Capital Markets and Truist Securities.
ADC Therapeutics entered into a $115 million convertible credit facility with funds affiliated with Deerfield Management Company.
Acutus Medical completed a $170 million financing, including a $100 million Series D equity financing and a $70 million credit facility.
As part of its voluntary Chapter 11 petitions, Adeptus Health will receive $45 million in debtor-in-possession financing from Deerfield Management Company, which will gain ownership of Adeptus.
Recovery Centers of America secured a $231.5 million commitment from New York-based healthcare investment firm Deerfield Management.